Alternative Data for LabCorp
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,307 | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 15,961,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 244 | Sign up | Sign up | Sign up |
| Facebook Followers | 17,339 | Sign up | Sign up | Sign up |
| Instagram Followers | 15,434 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,113 | Sign up | Sign up | Sign up |
| X Followers | 8,578 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 6,490 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 65 | Sign up | Sign up | Sign up |
| Linkedin Employees | 41,292 | Sign up | Sign up | Sign up |
About LabCorp
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries.
| Price | $270.87 |
| Target Price | Sign up |
| Volume | 1,060,000 |
| Market Cap | $22.5B |
| Year Range | $239.37 - $290.15 |
| Dividend Yield | 1.07% |
| PE Ratio | 26.61 |
| Analyst Rating | 89% buy |
| Earnings Date | February 17 '26 |
| Industry | Health Care Services |
In the news
 |
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72January 16 - Yahoo |
|
Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion?January 15 - Yahoo |
 |
Labcorp Holdings Inc. (LH) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 13 - SeekingAlpha |
|
Assessing Labcorp Holdings (LH) Valuation After A Recent 10.5% Three Month Share Price DeclineJanuary 12 - Yahoo |
|
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now?December 21 - Yahoo |
|
Labcorp’s Contract Research Slowdown and Oncology Push Could Be A Game Changer For Labcorp Holdings (LH)December 15 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 3.56B | 2.54B | 1.03B | 261M | 564M | 4.180 |
| Q2 '25 | 3.53B | 2.48B | 1.05B | 238M | 532M | 4.350 |
| Q1 '25 | 3.35B | 2.4B | 948M | 213M | 498M | 3.840 |
| Q4 '24 | 3.33B | 2.43B | 896M | 143M | 418M | 3.450 |
| Q3 '24 | 3.28B | 2.38B | 904M | 169M | 423M | 3.500 |
Insider Transactions View All
| Schechter Adam H filed to sell 87,574 shares at $262.8. November 13 '25 |
| Parham Richelle P filed to sell 2,469 shares at $254.3. November 4 '25 |
| Van Der Vaart Sandra D filed to sell 2,274 shares at $271.4. August 15 '25 |
| Schechter Adam H filed to sell 93,319 shares at $266.8. August 13 '25 |
| Gilliland Dwight Gary filed to sell 6,656 shares at $265. August 1 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| April Delaney |
Dec 9, 25 | Buy | $1K - $15K |
| Ro Khanna |
Nov 14, 25 | Sell | $1K - $15K |
| April Delaney |
Nov 5, 25 | Buy | $1K - $15K |
Read more about LabCorp (LH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - LabCorp
The Market Cap of LabCorp is $22.5B.
As of today, LabCorp's PE (Price to Earnings) ratio is 26.61.
LabCorp will report its next earnings on February 17 '26.
Currently, the price of one share of LabCorp stock is $270.87.
The LH stock price chart above provides a comprehensive visual representation of LabCorp's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LabCorp shares. Our platform offers an up-to-date LH stock price chart, along with technical data analysis and alternative data insights.
Yes, LabCorp (LH) offers dividends to its shareholders, with a dividend yield of 1.07%. This dividend yield represents LabCorp's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LabCorp in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of LabCorp are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
